Chemed Corporation (NYSE: CHE) reported Q4 EPS of $1.80, $0.11 better than the analyst estimate of $1.69. Revenue for the quarter came in at $379 million versus the consensus estimate of $372.54 million.

Chemed Corporation sees FY2015 EPS of $6.50-$6.70, versus the consensus of $6.31.

For earnings history and earnings-related data on Chemed Corporation (CHE) click here.